We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Β Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.775063 | 0.775063 | 0.775063 | 0 | 0 | CS |
4 | 0 | 0 | 0.775063 | 0.775063 | 0.775063 | 0 | 0 | CS |
12 | 0 | 0 | 0.775063 | 0.775063 | 0.775063 | 0 | 0 | CS |
26 | 0 | 0 | 0.775063 | 0.775063 | 0.775063 | 0 | 0 | CS |
52 | 0 | 0 | 0.775063 | 0.775063 | 0.775063 | 0 | 0 | CS |
156 | -74.124937 | -98.9652029372 | 74.9 | 103.6 | 0.75 | 1292608 | 40.90371341 | CS |
260 | -51.724937 | -98.5236895238 | 52.5 | 163.8 | 0.75 | 3072255 | 66.40220962 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions